Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 4 1Phase 3 1Phase 2 1

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Depression 4Anxiety Disorders 3Pancreatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1

Interventions

Ketamine 3Psilocybin 1Niacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Anxiety Disorders × Ketamine × Clear all
NCT05086250 2026-05-08

Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Gastrointestinal

Anxiety Disorders, Pancreatic Neoplasms

NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

NCT05344625 2024-01-24

KAPTIVATED

Northwell Health

Phase EARLY_PHASE1 Withdrawn

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡